What does this research mean for the field?

Early-onset, refractory allergic conditions can be the primary manifestation of inborn errors of immunity, and targeted biologic therapies can effectively improve these severe allergic symptoms. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to improve awareness and management strategies for pediatric patients with inborn errors of immunity presenting with allergic symptoms.

May 20, 2026American Journal of Respiratory and Critical Care Medicine

A60-16 Clinical Phenotypes and Therapeutic Exploration of 10 Cases of Inborn Errors of Immunity With Prominent Allergic Manifestations

View Full Paper

Ask AI

Bookmark

Authors

LLL Li CYC Yang XWX Wu

Discussion

Member takes

Overview

Retrospective study explores allergic outcomes in pediatric patients with inborn errors of immunity, suggesting effective biologic therapies.

Key Points

The study aims to improve awareness and management strategies for pediatric patients with inborn errors of immunity presenting with allergic symptoms.
Analyzed clinical data and treatment outcomes of 10 pediatric patients from 2019 to 2025.
Utilized whole-exome sequencing to identify genotypes linked to allergic manifestations.
Conducted retrospective analysis of symptoms, treatments, and follow-up information.
Most patients exhibited eczema and atopic dermatitis, with high total IgE levels (>1000 kU/L in five patients).
Treatment with biologics such as dupilumab significantly improved dermatitis and pruritus in certain cases.
One patient with Omenn syndrome unfortunately died from a severe infection.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5100f03e14405aa9d318 https://doi.org/10.1093/ajrccm/aamag162.3362

View Full Paper

Ask AI

Bookmark

May 20, 2026American Journal of Respiratory and Critical Care Medicine

A60-16 Clinical Phenotypes and Therapeutic Exploration of 10 Cases of Inborn Errors of Immunity With Prominent Allergic Manifestations

View Full Paper

Ask AI

Bookmark

Authors

LLL Li CYC Yang XWX Wu

Discussion

Member takes

Overview

Retrospective study explores allergic outcomes in pediatric patients with inborn errors of immunity, suggesting effective biologic therapies.

Key Points

The study aims to improve awareness and management strategies for pediatric patients with inborn errors of immunity presenting with allergic symptoms.
Analyzed clinical data and treatment outcomes of 10 pediatric patients from 2019 to 2025.
Utilized whole-exome sequencing to identify genotypes linked to allergic manifestations.
Conducted retrospective analysis of symptoms, treatments, and follow-up information.
Most patients exhibited eczema and atopic dermatitis, with high total IgE levels (>1000 kU/L in five patients).
Treatment with biologics such as dupilumab significantly improved dermatitis and pruritus in certain cases.
One patient with Omenn syndrome unfortunately died from a severe infection.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5100f03e14405aa9d318 https://doi.org/10.1093/ajrccm/aamag162.3362

View Full Paper

Ask AI

Bookmark